Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Biochemical Pharmacology

• Publication date

  2010-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bcp.2010.02.016PMID 20206143
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Artemisinin dimer anticancer activity correlates with heme‐catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction

  2009cited by this paper
• GA3, a new gambogic acid derivative, exhibits potent antitumor activities in vitro via apoptosis-involved mechanisms

  2009cited by this paper
• Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy

  2008cited by this paper
• Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action

  2008cited by this paper
• HSP105 interacts with GRP78 and GSK3 and promotes ER stress-induced caspase-3 activation.

  2008cited by this paper
• Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species

  2008cited by this paper
• Batracylin (NSC 320846), a dual inhibitor of DNA topoisomerases I and II induces histone gamma-H2AX as a biomarker of DNA damage.

  2007cited by this paper
• Evidence for the Involvement of Carbon-centered Radicals in the Induction of Apoptotic Cell Death by Artemisinin Compounds*

  2007cited by this paper
• Caspase-8 preferentially senses the apoptosis-inducing action of NG-18, A gambogic acid derivative, in human leukemia HL-60 cells

  2007cited by this paper
• Dihydroartemisinin is an inhibitor of ovarian cancer cell growth

  2007cited by this paper
• Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/β‐catenin pathway

  2007cited by this paper
• The ubiquitin-specific protease USP28 is required for MYC stability

  2007cited by this paper
• The Ins and Outs of MYC Regulation by Posttranslational Mechanisms*

  2006cited by this paper
• The Myc oncoprotein as a therapeutic target for human cancer.

  2006cited by this paper
• Activation of aminoflavone (NSC 686288) by a sulfotransferase is required for the antiproliferative effect of the drug and for induction of histone gamma-H2AX.

  2006cited by this paper
• Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function.

  2006cited by this paper
• Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy.

  2005cited by this paper
• Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo.

  2005cited by this paper
• Cancer therapeutics: targeting the dark side of Myc.

  2005cited by this paper
• Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells

  2005cited by this paper
• Comparative immunohistochemical analysis of pediatric Burkitt lymphoma and diffuse large B-cell lymphoma.

  2004cited by this paper
• Characterization of salvicine‐resistant lung adenocarcinoma A549/SAL cell line

  2004cited by this paper
• Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.

  2004cited by this paper
• The Life Cycle of C-Myc: From Synthesis to Degradation

  2004cited by this paper
• A medicinal chemistry perspective on artemisinin and related endoperoxides.

  2004cited by this paper
• Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate.

  2004cited by this paper
• A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells

  2004cited by this paper
• Antimalarial dihydroartemisinin also inhibits angiogenesis

  2004cited by this paper
• The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription.

  2003cited by this paper
• Phosphorylation by Glycogen Synthase Kinase-3 Controls c-Myc Proteolysis and Subnuclear Localization*

  2003cited by this paper
• Molecular modes of action of artesunate in tumor cell lines.

  2003cited by this paper
• Low molecular weight inhibitors of Myc–Max interaction and function

  2003cited by this paper
• Skp2 regulates Myc protein stability and activity.

  2003cited by this paper
• Synthesis and cytotoxicity of dihydroartemisinin ethers containing cyanoarylmethyl group.

  2003cited by this paper
• c-MYC: more than just a matter of life and death

  2002cited by this paper
• Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts

  2002cited by this paper
• mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether.

  2002cited by this paper
• Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC

  2002cited by this paper
• The anti-malarial artesunate is also active against cancer.

  2001cited by this paper
• Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

  2000cited by this paper
• A gene expression database for the molecular pharmacology of cancer

  2000cited by this paper
• MYC oncogenes and human neoplastic disease

  1999cited by this paper
• Direct activation of TERT transcription by c-MYC

  1999cited by this paper
• Influence of increased c-Myc expression on the growth characteristics of human melanoma.

  1999cited by this paper
• c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism

  1999cited by this paper
• A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins.

  1995cited by this paper
• Progress in the research of artemisinin-related antimalarials: An update

  1994cited by this paper
• Over-expression of the c-myc proto-oncogene in colorectal carcinoma.

  1993cited by this paper

• Centella Asiatica Fraction-3 Enhances Antioxidant Capacity and Apoptotic Cell Death in HEK293 Kidney Cells

  2025cites this paper
• Bibliometric and Visualized Analysis of Artemisinin and Its Derivatives in Cancer

  2025cites this paper
• Dihydroartemisinin Inhibits Oral Cancer Cell Migration, associated with Impairment of Cytoskeleton Organization and Cell Membrane Fluidity

  2025cites this paper
• Discovery of 4-(4-(3-(1-(2-(piperidin-1-yl)ethyl)-1H-benzo[d]imidazole-2-yl)isoxazol-5-yl)phenyl)morpholine as a novel c-Myc inhibitor against lung cancer in vitro and in vivo.

  2024cites this paper
• Dihydroartemisinin enhances the radiosensitivity of breast cancer by targeting ferroptosis signaling pathway through hsa_circ_0001610.

  2024cites this paper
• Bioinformatic analysis of hippocampal histopathology in Alzheimer’s disease and the therapeutic effects of active components of traditional Chinese medicine

  2024cites this paper
• Targeting Transcription Factors in Cancer: From "Undruggable" to "Druggable".

  2023cites this paper
• Unlocking the power of nanomedicine: the future of nutraceuticals in oncology treatment

  2023cites this paper
• An Overview of Dihydroartemisinin as a Promising Lead Compound for Development of Anticancer Agents.

  2022cites this paper
• Anticancer Potential of Artemisinin Derivatives Containing Fluorine Atoms

  2022cites this paper
• Centella asiatica Modulates Nrf-2 Antioxidant Mechanisms and Enhances Reactive Oxygen Species-Mediated Apoptotic Cell Death in Leukemic (THP-1) Cells

  2022cites this paper
• Pharmacological properties and mechanism insights of Moroccan anticancer medicinal plants: What are the next steps?

  2020cites this paper
• Cadmium Exposure Elevates Glutathione Concentration via the Increase of C-Myc that Contributes to Attenuate the Toxicity of the Cells

  2020cites this paper
• Artemisinin and its derivatives: a promising cancer therapy

  2020cites this paper
• Application of star poly(ethylene glycol) derivatives in drug delivery and controlled release.

  2020cites this paper
• Induction of GNMT by 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranoside through proteasome-independent MYC downregulation in hepatocellular carcinoma

  2019cites this paper
• Immunoregulatory Properties of Arteether in Folic Acid-Chitosan-Fe3O4 Composite Nanoparticle in 4T1 Cell Line and Mice Bearing Breast Cancer

  2019cites this paper
• Synthesis of novel S-linked dihydroartemisinin derivatives and evaluation of their anticancer activity.

  2019cites this paper
• Natural Products as Cytotoxic Agents in Chemotherapy against Cancer

  2018cites this paper
• Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches

  2018cites this paper
• More insights into the pharmacological effects of artemisinin

  2018cites this paper
• Dihydroartemisinin triggers c-Myc proteolysis and inhibits protein kinase B/glycogen synthase kinase 3β pathway in T-cell lymphoma cells.

  2018cites this paper
• Effect of dihydroarteminin combined with siRNA targeting Notch1 on Notch1/c-Myc signaling in T-cell lymphoma cells.

  2018cites this paper
• Shikonin suppresses proliferation and induces apoptosis in human leukemia NB4 cells through modulation of MAPKs and c-Myc

  2017cites this paper
• Dihydroartemisinin Induces Apoptosis in Human Bladder Cancer Cell Lines Through Reactive Oxygen Species, Mitochondrial Membrane Potential, and Cytochrome C Pathway

  2017cites this paper
• Macrocyclic peptides decrease c-Myc protein levels and reduce prostate cancer cell growth

  2017cites this paper
• Centella asiatica Fraction-3 Suppresses the Nuclear Factor Erythroid 2-Related Factor 2 Anti-Oxidant Pathway and Enhances Reactive Oxygen Species-Mediated Cell Death in Cancerous Lung A549 Cells

  2017cites this paper
• An in vitro investigation into the anti-proliferative and anti-inflammatory properties of centella asiatica (linnaeus) urban (leaf) and withania somnifera (linnaeus) dunal (root) extracts.

  2017influential citation
• Design of Drug Delivery Systems Containing Artemisinin and Its Derivatives

  2017cites this paper
• Artemether suppresses cell proliferation and induces apoptosis in diffuse large B cell lymphoma cells

  2017cites this paper
• Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling

  2016cites this paper
• Encapsulation of low lipophilic and slightly water-soluble dihydroartemisinin in PLGA nanoparticles with phospholipid to enhance encapsulation efficiency and in vitro bioactivity

  2016cites this paper
• Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?

  2016cites this paper
• Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast caner cells and osteoclasts

  2016cites this paper
• Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells.

  2016cites this paper
• Phospho-TCTP as a therapeutic target of dihydroartemisinin for aggressive breast cancer cells

  2015cites this paper
• Anticancer Effect of AntiMalarial Artemisinin Compounds

  2015cites this paper
• Direct and indirect targeting of MYC to treat acute myeloid leukemia

  2015cites this paper
• Structurally diverse c-Myc inhibitors share a common mechanism of action involving ATP depletion

  2015influential citation
• Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway.

  2015cites this paper
• DNA damage in dihydroartemisinin-resistant Molt-4 cells.

  2015cites this paper
• MYC-mediated synthetic lethality for treating tumors.

  2015cites this paper
• Small-molecule inhibitors of the Myc oncoprotein.

  2015cites this paper
• Anticancer Effect of AntiMalarial Artemisinin Compounds

  2015cites this paper
• Attacking c-Myc: targeted and combined therapies for cancer.

  2014cites this paper
• Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis

  2014cites this paper
• DJ-1 mediates the resistance of cancer cells to dihydroartemisinin through reactive oxygen species removal.

  2014cites this paper
• Development of a dihydroartemisinin-resistant Molt-4 leukemia cell line.

  2014cites this paper
• Novel Multiarm Polyethylene glycol-Dihydroartemisinin Conjugates Enhancing Therapeutic Efficacy in Non-Small-Cell Lung Cancer

  2014cites this paper
• A Screening-Based Approach to Circumvent Tumor Microenvironment-Driven Intrinsic Resistance to BCR-ABL+ Inhibitors in Ph+ Acute Lymphoblastic Leukemia

  2014cites this paper
• Artemisinin in Cancer Therapy

  2014cites this paper
• Enhanced apoptotic effects of dihydroartemisinin-aggregated gelatin and hyaluronan nanoparticles on human lung cancer cells.

  2014cites this paper
• Stereospecific ligands and their complexes. Part XII. Synthesis, characterization and in vitro antiproliferative activity of platinum(IV) complexes with some O,O′-dialkyl esters of (S,S)-ethylenediamine-N,N′-di-2-propanoic acid against colon cancer (HCT-116) and breast cancer (MDA-MB-231) cell lines

  2014cites this paper
• Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells.

  2014cites this paper
• Inhibitory Effect of Herbal Remedy PERVIVO and Anti-Inflammatory Drug Sulindac on L-1 Sarcoma Tumor Growth and Tumor Angiogenesis in Balb/c Mice

  2013cites this paper
• Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate

  2013cites this paper
• The Use of Artemisinin Compounds as Angiogenesis Inhibitors to Treat Cancer

  2013cites this paper
• Preparation and optimization of transferrin-modified-artemether lipid nanospheres based on the orthogonal design of emulsion formulation and physically electrostatic adsorption.

  2013cites this paper
• An electrochemical immunosensor based on gold nanoparticle tags for picomolar detection of c-Myc oncoprotein

  2013cites this paper
• In vitro evaluation of efficacy of dihydroartemisinin‐loaded methoxy poly(ethylene glycol)/poly(l‐lactic acid) amphiphilic block copolymeric micelles

  2013cites this paper
• Development of artemisinin compounds for cancer treatment

  2013cites this paper
• Ionizing Radiation Potentiates Dihydroartemisinin-Induced Apoptosis of A549 Cells via a Caspase-8-Dependent Pathway

  2013cites this paper
• Cytotoxicity of dihydroartemisinin toward Molt-4 cells attenuated by N-tert-butyl-alpha-phenylnitrone and deferoxamine.

  2013cites this paper
• Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells

  2013cites this paper
• Alkaloids Isolated from Natural Herbs as the Anticancer Agents

  2012cites this paper
• [Preparation and characterization of dihydroartemisinin/ hydroxypropyl-beta-cyclodextrin inclusion complex].

  2012cites this paper
• Histone Deacetylase Inhibitors Facilitate Dihydroartemisinin-Induced Apoptosis in Liver Cancer In Vitro and In Vivo

  2012cites this paper
• Addiction to c-MYC in multiple myeloma.

  2012cites this paper
• Dihydroartemisinin-induced inhibition of proliferation in BEL-7402 cells: an analysis of the mitochondrial proteome.

  2012cites this paper
• Induction of apoptosis by 3-amino-6-(3-aminopropyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline via modulation of MAPKs (p38 and c-Jun N-terminal kinase) and c-Myc in HL-60 human leukemia cells.

  2012cites this paper
• Discovery of Dihydroartemisinin and Dasatinib Drug Combination to Cure Poor-outcome BCR-ABL+ Acute Lymphoblastic Leukemia

  2012cites this paper
• Qinghaosu (artemisinin): Chemistry and pharmacology

  2012cites this paper
• Terpenoids: natural products for cancer therapy

  2012influential citation
• Hypoxia modulates the effect of dihydroartemisinin on endothelial cells.

  2011cites this paper
• Antitumor Activity of Artemisinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug

  2011influential citation
• The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells

  2011influential citation
• Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line

  2011cites this paper
• Anti-cancer natural products isolated from chinese medicinal herbs

  2011cites this paper